Andrew Pierce

Translational Sciences Oncology

Andrew Pierce is an associate director of Translational Science Oncology at AstraZeneca, with a focus on implementing biomarkers in early phase clinical development to inform drug dose/scheduling, mechanism of action and patient selection.
Copyright 2017 © BCF GROUP. All rights reserved.